Accuray | ARAY - SCHULD





SCHULD Veränderung Datum
Abbott USD 34.05B 20.19B 2026-03
Accuray USD 170.24M 4.52M 2024-09
AngioDynamics USD 6.3M 6.3M 2025-02
Artivion USD 317.78M 619K 2024-12
AtriCure USD 71.78M 1.6M 2026-03
Boston Scientific USD 11.03B 407M 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Inogen USD 0 0 2022-06
Mesa Laboratories USD 204.98M 7.27M 2024-09
Orthofix International USD 137.23M 338K 2024-09
Tandem Diabetes Care USD 444.48M 4.81M 2025-12
Trinity Biotech USD 137.98M 37.22M 2025-12